Skip to main content

Glipizide

NDC 70518-3898 · REMEDYREPACK INC.

Generic nameGlipizide
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)GLIPIZIDE
Strength5 mg/1
Pharmacologic classSulfonylurea Compounds [CS], Sulfonylurea [EPC]
Marketing categoryANDA

Packages

70518-3898-0 — 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-3898-0)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

69584-309 — Glipizide, 69584-310 — Glipizide, 70518-0373 — Glipizide and Metformin Hydrochloride, 70518-0552 — Glipizide, 70518-0579 — Glipizide, 70518-1063 — Glipizide, 70518-1848 — Glipizide, 70518-2308 — Glipizide, 70518-3645 — Glipizide, 70518-3896 — Glipizide, 70518-4128 — Glipizide, 71205-041 — Glipizide, 71205-270 — Glipizide and Metformin HCl, 71335-0618 — Glipizide, 71335-0930 — Glipizide, 71335-1031 — Glipizide, 71335-1042 — Glipizide, 71335-1130 — Glipizide, 71335-2353 — Glipizide, 71335-2520 — Glipizide, +132 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels